Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Marysville
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Marysville, WA

Studies commonly pay $75 to $4,500 per completed study

200 clinical trials are currently recruiting participants within 30 miles of Marysville. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

200studies recruiting
7+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Marysville right now

Top 25 of 200 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

Schizophrenia, Autism-Related Irritability Phase 3 Interventional 400 participants sought
Local Institution - 0155 — Everett, Washington (7.4 mi) · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See eligibility & contact on ClinicalTrials.gov (NCT07424404)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Macular Degeneration, Age-Related Macular Degeneration Phase 2, Phase 3 Interventional 960 participants sought
Pacific Northwest Retina (Site 112) — Burlington, Washington (28.4 mi) · Sponsor: EyeBiotech Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07440225)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder Phase 3 Interventional 200 participants sought
Neurocrine Clinical Site — Everett, Washington (7.4 mi) · Sponsor: Neurocrine Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT06786624)

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Phase 3 Interventional 466 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07321652)

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Episodic Migraine Phase 3 Interventional 450 participants sought
Core Clinical Research /ID# 249721 — Everett, Washington (7.4 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT05711394)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Urothelial Cancer, Advanced/Metastatic Urothelial Cancer Phase 1, Phase 2 Interventional 132 participants sought
Eye Associates Northwest - Edmonds Clinic — Edmonds, Washington (21.3 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07421700)

Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer

Miscellaneous Neoplasm, Nos, Non-Neoplastic Condition, Nos N/A Interventional 535 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT07091617)

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06580314)

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

Episodic Migraine Phase 3 Interventional 990 participants sought
EvergreenHealth Research Department, Merz Investigational Site #0010516 — Kirkland, Washington (27.7 mi) · Sponsor: Merz Therapeutics GmbH
See eligibility & contact on ClinicalTrials.gov (NCT07018700)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Metastatic Melanoma, Unresectable Melanoma Phase 3 Interventional 670 participants sought
Swedish Cancer Institute — Edmonds, Washington (21.3 mi) · Sponsor: Iovance Biotherapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05727904)

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 700 participants sought
Swedish Cancer Institute - Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06890598)

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

Relapsing Multiple Sclerosis Phase 3 Interventional 800 participants sought
TG Therapeutics Investigational Trial Site — Kirkland, Washington (27.7 mi) · Sponsor: TG Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05877963)

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Breast Cancer N/A Observational 30,000 participants sought
Skagit Valley Hospital — Mount Vernon, Washington (24.9 mi) · Sponsor: Agendia
See eligibility & contact on ClinicalTrials.gov (NCT03053193)

Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma Phase 3 Interventional 421 participants sought
Swedish Cancer Institute-Edmonds — Edmonds, Washington (21.3 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05976763)

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Central Line Associated Blood Stream Infections (CLABSI) N/A Interventional 17,800 participants sought
Providence Regional Medical Center Everett — Everett, Washington (7.4 mi) · Sponsor: Swedish Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT07108660)

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm N/A Interventional 80 participants sought
Providence Regional Cancer Partnership — Everett, Washington (7.4 mi) · Sponsor: Fred Hutchinson Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT07141407)
Actively enrolling

Studies you may be able to join near Marysville

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for cirrhosis caused by MASH

Enrolling adults aged 18 to 80 with a physician diagnosis of liver cirrhosis caused by MASH (metabolic dysfunction-associated steatohepatitis). Not open to people with treated ascites, variceal bleeding, hepatitis B or C, or alcohol-related liver disease.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Marysville

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Core Clinical Research

★ 4.2
2918 Colby Ave, Everett, WA 98201
(425) 443-9551
"I appreciate everyone on the team here, the staff was very kind and welcoming, quiet environment. Very thorough process, but pretty easy!"
— Drake Thompson, 5★

Northwest Clinical Research Center

★ 3.9
1951 152nd Pl NE #200, Bellevue, WA 98007
(425) 453-0404
"Great staff and awesome research studies."
— Linda Martinez, 5★

Providence Everett Center for Clinical Research

★ 1.0
1330 Rockefeller Ave Ste 440, Everett, WA 98201
(425) 261-4069

Clinical Research: Western Washington Medical Group

★ 5.0
12728 19th Ave SE Ste 300, Everett, WA 98208
(425) 225-2760

Rainier Clinical Research Center

★ 4.3
800 SW 39th St Ste 110, Renton, WA 98057
(425) 251-1720
"I have been participating in Type 1 Diabetes studies at Rainier Clinical for at least 15 years and until recently have been impressed with the manage…"
— Annalise k, 3★

Seattle Clinical Research Center

★ 5.0
633 Yesler Wy, Seattle, WA 98104
(206) 522-3330
"I have been part of a vaccine trial here and the staff are so kind. I have a lot of medical anxiety due to some poor experiences. Typically, being in…"
— Kamla Anand Corder, 5★

Clinical Research Center at Minor

★ 4.7
820 Minor Ave N, Seattle, WA 98109
(206) 667-7100
"Wonderful staff, supportive environment"
— Susan Mausshardt, 5★

Clinical trials in Marysville: what's recruiting

The Marysville area currently has 200 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Marysville, the most active research areas are:

  • Cancer & Oncology12 studies
  • Brain & Mental Health3 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Marysville, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Marysville

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Marysville participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Marysville pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Marysville safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Marysville, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Marysville typically complete one or two studies per year.

Paid clinical trials near Marysville

Other metros within reach

Bellevue, WA1,520 Seattle, WA1,510 Bremerton, WA1,481 Tacoma, WA1,464 Olympia, WA234 Vancouver, WA1,021 Portland, OR1,021 Salem, OR116

By condition

Eligibility and exclusions, condition by condition

MASH (cirrhosis due to MASH) in Marysville Bladder Issues Due To Spinal Cord Injury in Marysville All conditions

More of WA

Bellevue1,520 Seattle1,510 Bremerton1,481 Tacoma1,464 Vancouver1,021 Spokane291 Olympia234 Kennewick55

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts